Rheumatology

The following highlights spotlight several fascinating and timely abstracts presented at the European Alliance of Associations for…

In fact, patients with RA in the lowest low-density lipoprotein (LDL) group (<70 mg/dL) may experience an unexpectedly high CVD risk.2 The authors explored whether patients with LDL 130 mg/dL), as a reason for this risk.

Environmental air pollution has been linked to the pathogenesis of rheumatoid arthritis (RA).1 Nevertheless, there is no evidence linking higher concentrations of air pollutants with the risk of RA reactivations.

Takayasu arteritis (TA) is a chronic inflammatory large-vessel vasculitis, predominantly affecting the aorta and its main branches.

Lenabasum is an oral, non-immunosuppressive, cannabinoid Type 2 receptor agonist that activates resolution of innate immune responses.1 In animal models of bleomycin-induced skin and lung fibrosis, lenabasum reduced inflammation and fibrosis

Pneumocystis jiroveci pneumonia (PJP) is an opportunistic infection affecting immunocompromised individuals…

Musculoskeletal ultrasound (MSUS) biomarkers may have an important role to play in the evaluation of individuals…

It is now accepted that sustained remission is the key treatment goal for rheumatoid arthritis (RA). The availability of biologic therapies and the use of targeted treatment strategies has led to increasing numbers of patients achieving remission; however, specific guidance for the management of patients with RA in sustained clinical remission, treated with conventional synthetic disease-modifying anti-rheumatic drugs (cs-DMARDs), is lacking.